Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
2.
Int J Cancer ; 130(1): 179-89, 2012 Jan 01.
Article in English | MEDLINE | ID: mdl-21351088

ABSTRACT

Several risk factors have been identified for childhood lymphomas. The purpose of this meta-analysis was to synthesize current evidence regarding the association between birth weight with primarily the risk for non-Hodgkin lymphoma (NHL), given its similarity to acute lymphoblastic leukemia, Hodgkin lymphoma (HL) and any category of lymphoma. Two cohort (278,751 children) and seven case-control studies (2,660 cases and 69,274 controls) were included. Effects estimates regarding NHL, HL and any lymphoma were appropriately pooled using fixed or random effects model in two separate analyses: specifically, high was compared to normal or any birth weight. Similarly, low was compared to normal or any birth weight. No statistically significant association was found between high birth weight, as compared to normal birth weight, and risk for NHL plus Burkitt lymphoma (OR = 1.17, 95% CI = 0.76-1.80, random effects), HL (OR = 0.94, 95% CI = 0.64-1.38, fixed effects) or any plus Burkitt lymphoma (OR = 1.09, 95% CI = 0.76-1.56, fixed effects). A null association emerged when low was compared with normal birth weight for NHL plus Burkitt lymphoma (OR = 1.07, 95% CI = 0.71-1.62, random effects), HL (OR = 0.94, 95% CI = 0.54-1.65, fixed effects) or any plus Burkitt lymphoma (OR = 1.02, 95% CI = 0.79-1.33, fixed effects). Accordingly, no association was found when high or low birth weight was compared to any birth weight. Although current evidence suggests no association, birth weight might be a too crude indicator to reveal a genuine association of fetal growth with specific lymphoma categories; hence, there is an emerging need for use of more elaborate proxies, at least those accounting for gestational week.


Subject(s)
Birth Weight , Lymphoma/etiology , Case-Control Studies , Child , Humans , Risk Factors
3.
Int J Cancer ; 129(11): 2694-703, 2011 Dec 01.
Article in English | MEDLINE | ID: mdl-21225624

ABSTRACT

Results from epidemiological studies exploring the association between childhood lymphoma and maternal smoking during pregnancy have been contradictory. This meta-analysis included all published cohort (n = 2) and case-control (n = 10) articles; among the latter, the data of the Greek Nationwide Registry for Childhood Hematological Malignancies study were updated to include all recently available cases (-2008). Odds ratios (ORs), relative risks and hazard ratios were appropriately pooled in three separate analyses concerning non-Hodgkin lymphoma (NHL, n = 1,072 cases), Hodgkin lymphoma (HL, n = 538 cases) and any lymphoma (n = 1,591 cases), according to data availability in the included studies. An additional metaregression analysis was conducted to explore dose-response relationships. A statistically significant association between maternal smoking (any vs. no) during pregnancy and risk for childhood NHL was observed (OR = 1.22, 95% confidence interval, CI: 1.03-1.45, fixed effects model), whereas the risk for childhood HL was not statistically significant (OR = 0.90, 95% CI: 0.66-1.21, fixed effects model). The analysis on any lymphoma did not reach statistical significance (OR = 1.10, 95% CI = 0.96-1.27, fixed effects model), possibly because of the case-mix of NHL to HL. No dose-response association was revealed in the metaregression analysis. In conclusion, this meta-analysis points to a modest increase in the risk for childhood NHL, but not HL, among children born by mothers smoking during pregnancy. Further investigation of dose-response phenomena in the NHL association, however, warrants accumulation of additional data.


Subject(s)
Hodgkin Disease/etiology , Lymphoma, Non-Hodgkin/etiology , Pregnancy Complications, Neoplastic/etiology , Smoking/adverse effects , Case-Control Studies , Female , Follow-Up Studies , Humans , Mothers , Pregnancy , Prognosis , Risk Factors , Survival Rate
5.
J Inherit Metab Dis ; 30(6): 986, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17876723

ABSTRACT

Niemann-Pick Disease (NPD) is a heterogeneous group of autosomal recessive disorders characterized by progressive accumulation of sphingomyelin and cholesterol in lysosomes. Six types of NPD have been described based on clinical presentation and involved organs. The primary defect in NPD types A and B is a deficiency of lysosomal acid sphingomyelinase (ASM). We present a case of a 5-year-old boy with type B NPD who had severe clinical manifestations, including heart involvement. He was first admitted to the hospital at 2 months because of vomiting, refusal to feed, lethargy, hepatomegaly and mild transaminasaemia. Liver biopsy at 12 months showed lipid accumulation and fibrosis. Investigations for lysosomal storage disorders revealed increased plasma chitotriosidase (549 nmol/h per ml, normal value 0-150). At 18 months, no detectable ASM activity was observed in cultured fibroblasts (normal range 23-226 nmol/h per mg protein) confirming NPD B. Pulmonary involvement was detected with high-resolution computerized tomography which revealed reticulonodular infiltrations and thickening of the interlobular septa. At 2 years growth retardation and kyphosis were noted. At 2.5 years he manifested neurodevelopment regression, indicating CNS involvement. Cardiac involvement (grade III mitral valve insufficiency) developed at 4 years and heart failure at 5 years. Genetic analysis revealed two mutations: a H421Y mutation that is common in Saudi Arabian and Turkish patients, and a W32X mutation, which has been found in other Mediterranean patients.


Subject(s)
Niemann-Pick Diseases/enzymology , Sphingomyelin Phosphodiesterase/deficiency , Child , Cholesterol/metabolism , DNA Mutational Analysis , Fibroblasts/metabolism , Greece , Hexosaminidases/blood , Humans , Lung/metabolism , Lysosomes/metabolism , Male , Mutation , Myocardium/metabolism , Nervous System Diseases/metabolism , Tomography, X-Ray Computed/methods
6.
Cell Mol Life Sci ; 63(19-20): 2229-36, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16964579

ABSTRACT

Brucella has traditionally been considered a biological weapon. It was the subject of extensive offensive research in the past, and still belongs to category B pathogens on most lists. Its propensity for airborne transmission and induction of chronic debilitating disease requiring combined antibiotic regimens for treatment, its abundance around the world and its vague clinical characteristics defying rapid clinical diagnosis are some of the characteristics that apply to the pathogen's weapons potential. Yet minimal mortality, availability of treatment options, protracted inoculation period and the emergence of new, more virulent potential weapons means that its inclusion among agents of bioterrorism is nowadays mainly of historical significance. Nevertheless, in the interest of literacy and of avoiding panic, physicians and the public both should be aware of the most common zoonosis worldwide.


Subject(s)
Bioterrorism , Brucella/pathogenicity , Brucellosis , Animals , Brucellosis/diagnosis , Brucellosis/drug therapy , Brucellosis/microbiology , Brucellosis/transmission , Disease Outbreaks/prevention & control , Humans
7.
Infection ; 31(2): 121-4, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12682820

ABSTRACT

13 cases of osteomyelitis caused by Aspergillus nidulans have been previously reported in patients with chronic granulomatous disease (CGD). All of them have been associated with simultaneous pulmonary infection and have had an extremely poor outcome. We report an unusual case of femoral osteomyelitis due to A. nidulans in a 16-year-old male with CGD, without pulmonary involvement. Treatment with liposomal amphotericin B and granulocyte colony-stimulating factor as well as extensive surgical debridement followed by prolonged treatment with itraconazole resulted in an excellent clinical response.


Subject(s)
Aspergillosis/complications , Aspergillus nidulans , Femur , Granulomatous Disease, Chronic/complications , Osteomyelitis/microbiology , Adolescent , Amphotericin B/administration & dosage , Aspergillosis/diagnostic imaging , Aspergillosis/pathology , Aspergillosis/therapy , Aspergillus nidulans/drug effects , Aspergillus nidulans/isolation & purification , Aspergillus nidulans/pathogenicity , Granulomatous Disease, Chronic/diagnostic imaging , Granulomatous Disease, Chronic/pathology , Humans , Male , Tomography, X-Ray Computed
8.
J Hosp Infect ; 52(3): 185-91, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12419271

ABSTRACT

The environmental fungal load (FL) of three hospitals was studied in representative regions in Greece (Thessalonika, Northern Greece, Athens, Central Greece and Heraklion, Southern Greece). Air, surfaces and tap water from high-risk departments were sampled monthly during one year. Air FL was [median (range)] 10.6 (1.2-37), 5.5 (3-28.8) and 7.7 (3.1-12.1) cfu/m(3) at Thessalonika, Athens and Heraklion, respectively. Air FL was lower in winter and higher in summer and autumn but seldom above acceptable levels. Aspergillus spp. constituted 70.5% of the filamentous fungi isolated. Aspergillus niger was the most prevalent species in the air of all the hospitals followed by Aspergillus flavus and Aspergillus fumigatus. The least contaminated departments were the intensive care units, whilst most contaminated were the solid organ transplantation in Athens and haematology departments in Thessalonika. No correlation between fungal species, season, hospital or departments was observed. Sixty per cent of all surfaces examined yielded filamentous fungi and/or blastomycetes. While no fungi were recovered from water in Thessalonika and Athens, one-third of the samples in Heraklion (apart from those of ICU) yielded multiple fungal species. The higher air FL in Thessalonika and Athens was recorded in departments located close to renovation works. These findings suggest that the air and surface FL fluctuates over the year, is due to varying fungal species, but does not differ greatly among hospitals. The variation among hospitals, as well as the role of hospital water fungal contamination and appropriate measures to eliminate it, need further study.


Subject(s)
Air Microbiology , Environmental Monitoring/methods , Fungi/isolation & purification , Hospitals, General , Hospitals, University , Infection Control/methods , Water Microbiology , Aspergillus/isolation & purification , Cross Infection/etiology , Cross Infection/prevention & control , Epidemiological Monitoring , Greece/epidemiology , Hospital Design and Construction , Humans , Immunocompromised Host , Mycoses/etiology , Mycoses/prevention & control , Population Surveillance , Risk Factors , Seasons
SELECTION OF CITATIONS
SEARCH DETAIL
...